@therestoreclinic's TRT protocol criticism, fact-checked

What did @therestoreclinic actually say?

The creator reviewed a viewer's TRT protocol: 100mg of testosterone every four weeks, which they called a fundamentally flawed approach. Their core argument was that once-monthly injections create problematic hormone swings, and that the viewer should be getting "at least 200-300 milligrams per month, spread minimally across at least four to eight injections per month." That's the claim we're checking.

To be clear about what's actually being said here: they're arguing two separate things. First, that injection frequency matters, and monthly is too infrequent. Second, that 100mg per month is an inadequate total dose. These are related but distinct claims, and they have different levels of evidence behind them.

Does the science back this up?

On frequency, they're largely correct. On the specific dose ranges they named, the evidence gets more complicated, and the framing raises some concerns.

Testosterone cypionate and enanthate have half-lives of roughly 7-8 days (Dobs et al., 1999, Journal of Clinical Endocrinology and Metabolism). That means a single monthly injection produces a sharp supraphysiologic peak in the first week, followed by a steep crash well below therapeutic range before the next dose. This is well-documented and genuinely problematic. Studies supporting more frequent, smaller injections to maintain stable serum levels are solid, including Weinbauer and Nieschlag's work on pharmacokinetics published in the 1990s and confirmed repeatedly since.

The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018) support doses in the range of 75-100mg weekly or 150-200mg every two weeks for hypogonadal men, which lines up with the creator's monthly total but implies the frequency point is the stronger argument.

What did they get wrong (or right)?

They got the frequency argument right. Injecting testosterone cypionate once per month is genuinely inconsistent with how the drug behaves pharmacokinetically. Most endocrinologists and urologists would agree that monthly injections of a short-to-medium ester testosterone are a poor protocol design.

Where things get slippery is the dose guidance. Saying someone should be on "at least 200-300 milligrams per month" is presented as a near-universal correction, but that's not what the clinical literature supports as a blanket recommendation. Appropriate TRT dosing is individualized based on baseline testosterone levels, symptom burden, hematocrit, and response over time. The American Urological Association and the Endocrine Society both emphasize titration to mid-normal physiologic range, not a fixed dose floor.

There's also no mention in the video of monitoring: hematocrit elevation, estradiol levels, fertility impact, or any of the clinical variables that actually determine whether a protocol is appropriate. Calling a protocol "bad" without knowing the patient's lab values or symptoms is incomplete analysis at best.

What should you actually know?

If you're on TRT or considering it, here's what the evidence actually supports. Injection frequency matters because testosterone esters have defined half-lives, and monthly injections of cypionate or enanthate will almost certainly produce peaks and troughs outside the therapeutic window. More frequent, smaller doses, such as weekly or twice-weekly injections, produce more stable serum testosterone levels and are the current standard of care in most clinical guidelines.

But dose is not one-size-fits-all. The goal of TRT in hypogonadal men is to restore testosterone to the mid-normal physiologic range, typically 400-700 ng/dL depending on the guideline, not to hit a specific milligram number. What's adequate for one person may be excessive for another.

• Bhasin et al. (2018, Journal of Clinical Endocrinology and Metabolism) recommend targeting mid-normal testosterone levels, not a fixed dose
• Hematocrit should be monitored, as elevated red blood cell mass is a real risk with TRT
• Estradiol conversion varies by individual and can produce symptoms if unmanaged
• Anyone receiving TRT should be under medical supervision with regular lab monitoring

The creator is pointing at a real problem with monthly injections. They're less useful when they imply a specific dose range is universally appropriate without any clinical context.